Granulocyte colony-stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats

Critical Care Medicine

Volumn 24, Issue 5, 1996, Pages 820-826

  Lundblad, Runar ^a   Nesland, Jahn Marthin ^a   Giercksky, Karl Erik ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bacteria; Critical illness; Endothelin; Endotoxin; Granulocyte colony stimulating factor; Neutrophils; Peritonitis; Sepsis; Tumor necrosis factor

Indexed keywords

ENDOTHELIN 1; ENDOTOXIN; LACTIC ACID; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIOLOGY; CECUM; CONTROLLED STUDY; DOSE RESPONSE; HEMATOCRIT; HISTOLOGY; IMMUNE RESPONSE; INTESTINE PERFORATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RAT; SEPSIS; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL; SURVIVAL RATE;

ANIMALS; CECAL DISEASES; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ENDOTHELINS; ENDOTOXINS; GRANULOCYTE COLONY-STIMULATING FACTOR; INTESTINAL PERFORATION; MALE; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEPSIS; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030004301     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199605000-00016     Document Type: Article

References (55)

1. Lopez AF, Nicola NA, Burgess AW, et al: Activation of granulocyte cytotoxic function by purified mouse colony-stimulating factors. J Immunol 1983; 131:2983-2988
2. Sullivan R, Griffin JD, Simons ER, et al: Effects of recombinant human granulocyte and macrophage colony-stimulating factors on signal transduction pathways in human granulocytes. J Immunol 1987; 139:3422-3430
3. Wang JM, Chen ZG, Colella S, et al: Chemotactic activity of recombinant human granulocyte colony-stimulating factor. Blood 1988; 72:1456-1460
4. Ichinose Y, Hara N, Ohta M, et al: Recombinant granulocyte colony-stimulating factor and lipopolysaccharide maintain the phenotype of and superoxide anion generation by neutrophils. Infect Immun 1990; 58:1647-1652
5. Avalos BR, Gasson JC, Hedvat C, et al: Human granulocyte colony-stimulating factor: Biological activities and receptor characterization on hematopoietic cells and small lung cancer cell lines. Blood 1990; 75:851-857
6. Roilides E, Walsh TJ, Pizzo PA, et al: Granulocyte colony-stimulating factor enhances the phagocytotic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 1991; 163:579-583
7. Adachi S, Kubota M, Wakazono Y, et al: Mechanisms of enhancement of neutrophil survival by granulocyte colony-stimulating factor and adenine. Exp Hematol 1993; 21:1213-1218
8. Watanabe T, Itoh Y, Ogi K, et al: Synthesis of human endothelin-1 precursors in Escherichia coli. FEBS Lett 1989; 251:257-260
9. Kawakami M, Tsutsumi H, Kumakawa T, et al: Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 1990; 76: 1962-1964
10. Cebon J, Layton JE, Maher D, et al: Endogenous haemopoietic growth factors in neutropenia and infection. Br J Haematol 1994; 86:265-274
11. Pauksen K, Elfman L, Ulfgren A-K, et al: Serum levels of granulocyte colony-stimulating factor (G-CSF) in bacterial and viral infections, and in atypical pneumonia. Br J Haematol 1994; 88:256-260
12. Lieschke GJ, Grail D, Hodgson G, et al: Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 1994; 84: 1737-1746
13. Pittet JF, Morel DR, Hemsén A, et al: Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 1991; 213:261-264
14. Weitzberg E, Lundberg JM, Rudehill A: Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 1991; 33:222-227
15. Voerman HJ, Stehouwer CDA, van Kamp GJ, et al: Plasma endothelin levels are increased during septic shock. Crit Care Med 1992; 20:1097-1101
16. Lundblad R, Giercksky K-E: Endothelin concentrations in experimental sepsis: Profiles of big endothelin and endothelin 1-21 in lethal peritonitis in rats. Eur J Surg 1995; 161:9-16
17. Matsumoto M, Matsubara S, Yokota T: Effect of combination therapy with recombinant human granulocyte colony-stimulating factor (rG-CSF) and antibiotics in neutropenic mice unresponsive to antibiotics alone. J Antimicrob Chemother 1991; 28:447-453
18. Mooney DP, Gamelli RL, O'Reilly M, et al: Recombinant human granulocyte colony-stimulating factor and Pseudomonas burn wound sepsis. Arch Surg 1988; 123:1352-1357
19. Hebert JC, O'Reilly M, Gamelli RL: Protective effect of recombinant human granulocyte colony-stimulating factor against pneumococcal infections in splenectomized mice. Arch Surg 1990; 125:1075-1078
20. Nelson S, Summer W, Bagby G, et al: Granulocyte colony-stimulating factor enhances pulmonary host defenses in normal and ethanol-treated rats. J Infect Dis 1991; 164:901-906
21. Lang CH, Bagby GJ, Dobrescu C, et al: Effect of granulocyte colony-stimulating factor on sepsis-induced changes in neutrophil accumulation and organ glucose uptake. J Infect Dis 1992; 16: 336-343
22. O'Reilly M, Silver GM, Greenhalgh DG, et al: Treatment of intra-abdominal infection with granulocyte colony-stimulating factor. J Trauma 1992; 33: 679-682
23. Görgen I, Hartung T, Leist M, et al: Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor. J Immunol 1992; 149:918-924
24. Toda M, Murata A, Matsuura N, et al: Therapeutic efficacy of granulocyte colony stimulating factor against rat cecal ligation and puncture model. Stem Cells (Dayt) 1993; 11:228-234
25. Silver GM, Gamelli RL, O'Reilly M: The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival after Pseudomonas burn wound infection. Surgery 1989; 106:452-456
26. Cairo MS, Mauss D, Kommareddy S, et al: Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats. Pediatr Res 1990; 27:612-616
27. Yasuda H, Ajiki Y, Shimozato T, et al: Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice. Infect Immun 1990; 58:2502-2509
28. Lundblad R, Wang MY, Kvalheim G, et al: Granulocyte colony-stimulating factor improves myelopoiesis and host defense in fulminant intra-abdominal sepsis in rats. Shock 1995; 4:68-73
29. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986; 95:99-105
30. Almdahl SM, Nordstrand K, Melby K, et al: Faecal peritonitis in the rat. Acta Chir Scand 1985; 151:213-216
31. Lundblad R, Sandven P, Giercksky K-E: The physical nature of a large bowel perforation predicts severity of the subsequent inflammatory response. Shock 1995; 3:455-461
32. Offner F, Philippe J, Vogelaers D, et al: Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J Lab Clin Med 1990; 116:100-105
33. Calandra T, Baumgartner J-D, Grau GE, et al: Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-oc, and interferon-γ in the serum of patients with septic shock. J Infect Dis 1990; 161:982-987
34. Damas P, Ledoux D, Nys M, et al: Cytokine serum level during severe sepsis in human: IL-6 as a marker of severity. Ann Surg 1992; 215:356-362
35. Engelberts I, Stephens S, Franco GJM, et al: Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 1991; 338:515-516
36. Kanazawa M, Ishizaka A, Hasegava N, et al: Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs. Am Rev Respir Dis 1992; 145:1030-1035
37. Fink MP, O'Sullivan BP, Menconi MJ, et al: Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs. J Trauma 1993; 34:571-577
38. Matsumoto M, Matsubara S, Matsuno T, et al: Protective effect of human granulocyte colony-stimulating factor on microbial infection in neutropenic mice. Infect Immun 1987; 55:2715-2720
39. Eichacker PQ, Waisman Y, Natanson C, et al: Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J Appl Physiol 1994; 77:2366-2373
40. Hartung T, Döcke W-D, Gantner F, et al: Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 1995; 85:2482-2489
41. Ishikura H, Takada T, Yamagami K, et al: Therapeutic effect of recombinant granulocyte colony-stimulating factor (rhG-CSF) against experimental severe infections in rats. Abstr 565. Intensive Care Med 1994; 20(Suppl 1):S143
42. Hansen PB, Kjaersgaard E, Johnsen HE, et al: Different membrane expression of CD11b and CD14 on blood neutrophils following in vivo administration of myeloid growth factors. Br J Haematol 1993;85:50-56
43. Morise Z, Ueda M, Aiura K, et al: Pathophysiologic role of endothelin-1 in renal function in rats with endotoxin shock. Surgery 1994; 115:199-204
44. Dong LW, Chang YZ, Tong LJ, et al: Role of regulatory peptide in pathogenesis of shock. Sci China B 1994; 37:162-169
45. Xu D, Emoto N, Giaid A, et al: ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 1994; 78: 473-485
46. Kaw S, Emoto N, Jeng AY, et al: Pharmacological characterization of cloned human ECE-1 and ECE-2. Abstr C6. Fourth International Conference on Endothelin. London, UK, April 23-26, 1995
47. 125I-endothelin in the rat: Importance of pulmonary clearance. Biochem Biophys Res Commun 1990; 167:1191-1195
48. Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415
49. Ayala A, Perrin MM, Kisala JM, et al: Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor). Circ Shock 1992; 36:191-199
50. McMasters KM, Cheadle WG: Regulation of macrophage TNF α, IL-1β and Ia (I-Aα) mRNA expression during peritonitis is site dependent. J Surg Res 1993; 54:426-430
51. Sessa W, Kaw S, Hecker M, et al: The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes. Biochem Biophys Res Commun 1991; 174:613-618
52. Patrignani P, Del Maschio A, Bazzoni G, et al: Inactivation of endothelin by polymorphonuclear leukocyte-derived lytic enzymes. Blood 1991; 78:2715-2720
53. Lundblad R, Giercksky K-E: Effect of volume support, antibiotic therapy, and monoclonal antiendotoxin antibodies on mortality rate and blood concentrations of endothelin and other mediators in fulminant intra-abdominal sepsis in rats. Crit Care Med 1995; 23:1382-1390
54. Gillan ER, Christensen RD, Suen Y, et al: A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: Significant induction of peripheral and bone marrow neutrophilia. Blood 1994; 84:1427-1433
55. Weiss M, Gross-Weege W, Schneider M, et al: Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients. J Crit Care 1995; 10:21-26